Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study ...
Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson's disease, following completion of study preparations Espoo, Finland, 19 February 2026: Herantis Pharma ...
EET Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 Funding to support ...
This study presents a potentially valuable exploration of the role of thalamic nuclei in language processing. The results will be of interest to researchers interested in the neurobiology of language.
Researchers at The Hong Kong University of Science and Technology (HKUST) School of Engineering have achieved a major breakthrough in computational neural engineering. They have developed a novel ...
World-renowned immunologist strengthens scientific leadership and translational focusBOSTON, Feb. 19, 2026 /PRNewswire/ -- Vie Ventures, a life sciences ...
New research demonstrates that electroacupuncture can significantly alleviate pain-induced anxiety- and depression-like behaviors by modulating specific excitatory neurons in the brain. Using a mouse ...
And the presence of the Barcelona Science Park, which is the first science park in Spain that is home to three research institutes and more than 70 companies, make the city a viable location for ...
Programmed cell death (PCD) stands at the forefront of innovation in experimental pharmacology and drug discovery, providing fundamental insights into ...
News-Medical.Net on MSN
Study explores how reversible RNA editing could transform future cardiovascular medicine
By Hugo Francisco de Souza Emerging research suggests reversible RNA editing mechanisms may influence heart disease biology while opening new avenues for biomarkers and next-generation cardiovascular ...
Despite major advances in oncology, drug resistance remains one of the principal obstacles to achieving durable responses and cure in cancer patients. Both ...
As an innovative subtype of invasive brain-computer interfaces (BCIs), the Endovascular Brain-Computer Interface (EBCI) enables electrode delivery to target brain regions via endovascular intervention ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results